OBJECTIVES: Te aim of this analysis was to summarize the contribution of Colombian papers to ISPOR conferences from 1998 to 2013. METHODS: It was developed a review of ISPOR Scientific Presentations Database from 1998 to 2013, filtering by abstract, by the word “Colombia” for each ISPOR meeting (International, European, Asian, and Latin American), we obtained a list of all abstracts those ones without Colombian authors were excluded. Abstracts were classified by disease, topic, and topic subcategory taking into account the register of each one. It was taken into account if authors or abstract relate any support of pharmaceutical or/and devices industry. Descriptive statistics were applied by disease and study type. RESULTS: A total of 258 abstracts were identified, 25 were excluded because they have no Colombian authors; 233 abstracts were included in the analysis, 111 from International (47.6%), 12 from European (5.2%), 1 from Asia-Pacific (0.4%) and 109 from Latin America Conference (46.8%). Over time, cumulative numbers of abstracts are increasing exponentially. The majority of abstracts were costs studies (76.4%), followed by Health Care Use & Policy Studies (13.3%), Clinical Outcomes Studies (6.0%), and others (10, 4.3%). The three most frequent diseases were cancer (12.4%), vaccine (12.0%) and infections (10.3%). The three most frequent cost studies developed were classified as cost-effectiveness analysis (61.8%), Cost of Illness studies (10.7%) and budget impact analysis (9.0%); Of included studies, 51.9% contain any author related with pharmaceutical or/and devices industry. There may be underreporting of studies due the filter was applied only for abstract content, neither by title nor authors; underreport on Scientific Presentations Database; and underreporting of pharmaceutical industries support due it is not disclosed on abstract. CONCLUSIONS: The contribution of Colombia to ISPOR Conferences have been increasing markedly, going from 1 paper presented in 2004 to 93 papers presented in 2013